Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are at increased risk for COVID-19 related morbidity and mortality. Antibody response to COVID-19 vaccine in T2DM patients is not very clear. The present work aims to evaluate the antibody response to the inactivated SARS-CoV-2 vaccine in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yandong, Shen, Ping, Tao, Yue, Zhang, Wenjun, Xu, Biyun, Bi, Yan, Han, Zhen, Zhou, Yi-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773130/
https://www.ncbi.nlm.nih.gov/pubmed/36568756
http://dx.doi.org/10.3389/fpubh.2022.1025901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773130/
https://www.ncbi.nlm.nih.gov/pubmed/36568756
http://dx.doi.org/10.3389/fpubh.2022.1025901

Ejemplares similares